Jixing Pharmaceutical
is headquartered in Shanghai, Shanghai Municipality. Joseph Romanelli is the CEO of Jixing Pharmaceutical. Jixing Pharmaceutical has 1 followers on Owler. Jixing Pharmaceutical has an estimated revenue of <$1M and an estimate of less <10 employees.Jixing Pharmaceutical
is headquartered in Shanghai, Shanghai Municipality. Joseph Romanelli is the CEO of Jixing Pharmaceutical. Jixing Pharmaceutical has 1 followers on Owler. Jixing Pharmaceutical has an estimated revenue of <$1M and an estimate of less <10 employees.
Est. Annual Revenue
<$1M
Est. Employees
<10
News
May 09, 2022
Contract Pharma
Jixing Pharmaceutical: Hovione Signs Exclusive License Agreement with JIXING
Apr 18, 2022
Aithority
Jixing Pharmaceutical: LENZ Therapeutics and JIXING Announce an Exclusive Greater China License Agreement; RTW to Invest in LENZ Therapeutics
Apr 13, 2022
BioSpace
Jixing Pharmaceutical: LENZ Therapeutics and JIXING Announce an Exclusive Greater China License Agreement; RTW to Invest in LENZ Therapeutics
Mar 21, 2022
OINDPnews
Jixing Pharmaceutical: Ji Xing gets go-ahead for Phase 3 trial of OC-01 varenicline nasal spray for dry eye disease in China
Feb 16, 2022
PR Newswire Asia
Press Release: Jixing Pharmaceutical : JIXING ANNOUNCES RECEIPT OF BREAKTHROUGH THERAPY DESIGNATION FOR AFICAMTEN IN CHINA
Dec 20, 2021
BioSpace
Jixing Pharmaceutical: Cytokinetics and JI XING Announce Expansion of Collaboration to Include Licensing of Omecamtiv Mecarbil in China; RTW to Add to Its Investment in Cytokinetics
Aug 09, 2021
OINDPnews
Jixing Pharmaceutical: Ji Xing acquires Chinese rights to two Oyster Point nasal sprays for dry eye
Aug 05, 2021
BioSpace
Jixing Pharmaceutical: Oyster Point Pharma Announces Exclusive License Agreement with Ji Xing Pharmaceuticals to Develop and Commercialize OC-01 and OC-02 in Greater China
Jul 14, 2021
ChinaBio Today
Jixing Pharmaceutical: Ji Xing, a Shanghai Pharma, Completes B Round for Cardiovascular Drugs
Jul 13, 2021
MarketScreener
Jixing Pharmaceutical: RTW Investments :-Backed Ji Xing Pharmaceuticals Appoints Joseph Romanelli Chief Executive Officer